Homocysteine: A new risk factor for cardiovascular disease? Current knowledge and focus on a laboratory dosage technique;HOMOCYSTEINE. UN NOUVEAU FACTEUR DE RISQUE CARDIOVASCULAIRE? CONNAISSANCES ACTUELLES ET MISE AU POINT D'UNE TECHNIQUE DE DOSAGE AU LABORATOIRE

Feuillets de Biologie

Volumn 39, Issue 222, 1998, Pages 47-52

  Drouillard, I ^a   Adam, F ^a   Zagnoli, F ^a   Chianea, D ^a   Corbe, H ^a  

^a HIA Clermont Tonnerre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); COBALAMIN; CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE;

ARTICLE; BLOOD ANALYSIS; CYANOCOBALAMIN DEFICIENCY; DRUG DETERMINATION; ENZYME ACTIVITY; FOLIC ACID DEFICIENCY; HUMAN; HYPERHOMOCYSTEINEMIA; MUTATION; PATHOPHYSIOLOGY; RISK FACTOR; THROMBOEMBOLISM; VASCULAR DISEASE;

EID: 0031863170     PISSN: 04282779     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. BERWANGER C.-S., JEREMY J.-Y., STANSBY G. - Homocysteine and vascular disease. Br. J. Surg., 1995, 82 : 726-731.
2. BOWSHEY C.-J., BERESFORD S.-A.-A., OMENN G.-S., MOTULSKY A.-G. - A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA., 1995, 274 : 1049-1057.
3. BRATTSTROM L., ISRAELSSON B., NORWING B., BERGQVIST D., THÔRNE J., HULTBERG B., HAMFELT A. - Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis, 1990, 81 : 51-60.
4. BRATTSTROM L., ISRAELSSON B., JEPPSSON J.-O., HULTBERG B.-L. - Folic acid : an innocuous means to reduce plasma homocysteine. Scand. J. Clin. Lab. Invest., 1988, 48 : 215-221.
5. BRATTSTORM L., ISRAELSSON B., LINDEGARDE F., HULTBERRG B. - Higher total plasma homocysteine in vitamine B12 deficiency than in heterozygosity for homocystinuria due to cystathionine β synthase deficiency. Metabolism, 1988, 37 : 175-178.
6. CARSON N.-A.-J., NEILL D.-W. - Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch. Dis. Child., 1962, 37 : 505-513.
7. CHADEFAUX B., COUDE M., HAMET M., BIENVENU T., FRAIGNE P., AUPETIT J., KAMOUN P. - Dosage radioisotopique de la L-homocystéine totale dans le plasma et l'urine : application à tous les dosages en séries. Ann. Biol. Clin., 1990, 48 : 33-36.
8. CLARKE R., DALY L., ROBINSON K., NAUGHTEN E., CAHALANE S., FOWLER B., GRAHAM I. - Hyperhomocysteinemia : an independant risk factor for vascular disease. N. Engl. J. Med., 1991, 324 : 1149-1155.
9. CORELL B.-M., MALINOW M.-R., BEAMER N., SEXTON G., NORDT F., DE GARMO P. - Elevated plasma homocysteine concentration as a possible independant risk factor for stroke. Stroke, 1990, 21 : 572-576.
10. DE VIGNEAUD V.-E. - Trail of research in sulfur chemistry and metabolism, and related fields. Ithaca, New-York : Cornell University Press, 1952.
11. DUDMAN N.-P., WILCKEN D-.E., STOCKER R. - Circulating lipid hydroperoxide levels in human hyperhomocysteinemia. Relevance to development of artheriosclerosis. Arterioscler. Thromb., 1993, 13 : 512-516.
12. EVROVSKI J.,CALLAGHAN M.,COLE D.-E.-C. - Determination of homocysteine by HPLC with pulsed integrated amperometry. Clin. Chem., 1995, 41 : 757-759.
13. FALCON C.-R., CATTANEO M., PANZERI D., MARTINELLI I., MANNUCCI P.-M. - Hyperhomocysteinemia in venous thrombosis. Arterioscler. Thromb., 1994, 14 : 1080-1083.
14. FORTIN L.-J., GENEST J. - Measurement of homocysteine in the prediction of atherosclerosis. Clin. Biochem., 1995, 28 : 155-162.
15. FRANKEN D.-G., BOERS G.-H., BLOM H.-G., TRUBELS F.-J., KLOPPENBORG P-W. - Treatment of mild homocysteinemia in vascular disease patients. Arterioscler. Thromb., 1994, 14 : 465-470.
16. GIROUD M., GROSMAIRE N., LEMESLE M., GRAS P., VION P., DESGRES J., DUMAS R. - L'hyperhomocystéinémie, facteur de risque de l'infarctus cérébral. Presse Med., 1993, 22 : 35.
17. HARKER L.-A., ROSS R., SLIGHTER S.-J. - Homocystineinduced atherosclerosis. The role of endothelial cell injury and platelet respons in its genesis. J. Clin. Invest., 1976, 58 : 731-741.
18. HARKER L.-A., SLICHTER S.-J., SCOTT C.-R. - Homocysteinemia - Vascular injury and arterial thrombosis. N. Engl. J. Med., 1974, 291 : 537-543.
19. HARPEL P.-C., CHANG V-T., BORTH W. - Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein (a) to fibrin. A potential biochemical link between thrombosis, atherogenesis and sulfhydryl compound metabolism. Proc. Natl Acad. Sci. USA, 1992, 89 : 10193-10197.
20. HERNECKE J.-W., ROSEN H., SUZUKI L.-A., CHAIT A. - The role of sulfur-containing amino-acids in superoxyde production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem., 1987, 262 : 10098-100103.
21. ISRAELSON B., BRATTSTROM L.-E., HULTBERG B.-L. - Homocysteine and myocardial infarction. Atherosclerosis, 1988, 71 : 227-233.
22. JACOBSEN D.-W., GATAUTIS V-J., GREEN R. - Determination of plasma homocysteine by high performance liquid chromatography with fluorescence detection. Anal. Biochem., 1989, 178 : 208-214.
23. JACOBSEN D.-W., GATAUTIS V.-J., GREEN R., ROBINSON K., SAVON S.-R., SECIC M., OTTO J.-M., TAYLOR L.-M. - Rapid HPLC determination of total homocysteine and other thiols in serum and plasma : sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin. Chem., 1994, 40 : 873-881.
24. JULLIEN D. - L'homocystéine un nouveau facteur de risque cardiovasculaire. Diabétologie et facteurs de risque. 1996, 1-4: 129-133.
25. KANG S.-S., WONG P.-W.-K., NORUSIS M. - Homocysteinemia due to folate deficiency. Metabolism, 1987, 36 : 458-462.
26. KATAOKA H., TAKAGI K., MAKITA M. - Determination of total plasma homocysteine and related aminothiols by gas chromatography with flame photometric detection. J. Chromatogr. B. Biomed. Appl., 1995, 664 : 421-425.
27. KITTNER S.-J. - Homocystéine et ischémie cérébrale. STV, 1996, 8 : 603-606.
28. LENTZ S.-R., SADLER L.-E. - Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J. Clin. invest., 1991, 88 : 1906-1914.
29. Mc CULLY K.-S. - Vascular pathology of homocysteinemia : implications for the pathogenesis of atherosclerosis. Am. J. Pathol., 1969, 5 : 11-128.
30. Mc CULLY K.-S.- Homocysteine theory of atherosclerosis : development and current status. Atheroscler. Rev., 1983, 11 : 157-246.
31. MUDD S.-H., SKOVBY F., LEVY H.-L., PETTIGREW K.-D., WILCKEN B., PYERITZ R.-E., ANDRIA G., BOERS G.-H.-J., BROMBERG I.-L., CERONE R., FOWLER B., GROBE H., SCHMIDT H., SCHAVEITZER L. - The natural history of homocystinuria due to cystathionine b synthase deficiency. Am. J. Hum. Genet., 1985, 37 : 1-31.
32. MUDD S.-H., UHLENDORF B.-W., FREEMAN J.-M. - Homocystinuria associated with decreased methylene tetrahydrofolate reductase activity. Biochem. Biophys. Res. Common., 1972, 46: 905-912.
33. MURPHY-CHUTORIAN D., ALDERMAN E.-L. - The case that hyperhomocysteinemia is a risk factor for coronary artery disease. Am. J. Cardiol., 1994, 73 : 705-707.
34. PIOLOT A., NADLER F., PAREZ N., JACOTOT B. - L'homocystéine : ses liens avec les maladies cardiovasculaires ischémiques. Rev. Med. Interne, 1996, 17 : 34-45.
35. QUERE I., SCHVED J.-F., JANBON C. - Homocystéine et maladie thrombo-embolique veineuse. Actualités thrombose, 1996, 29 : 4-6.
36. ROLLAND P.-H. et Coll. - L'homocystéinémie : étiologie et pathogénie de ses manifestations cardiovasculakes. STV, 1990, 2 : 123-129.
37. SHIPCHANDLER M.-T., MOORE E.-G. - Rapid fully automated measurement of plasma homocysteine with the Abbott Imx Analyser. Clin. Chem., 1995, 41 : 991-994.
38. SMOLIN L.-A., SNEIDER J.-A. - Measurement of total plasma cysteamine using high-performance liquid chromatography with electrochemical detection. Anal. Biochem., 1988, 168 : 374-379.
39. STABLER S.-P., MARCELL R-D., PODELL E.-R., ALLEN R.-H. - Quantification of total homocysteine, total cysteine and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal. Biochem., 1987, 162 : 185-196.
40. STAMLER J.-S., OSBORNE J.-A., JARAKI O. - Adverse vascular effects of homocysteine are modulated by EDRF and related oxides of nitrogen. J. Clin. Invest., 1976, 91 : 308-318.
41. STAMLER J.-S., LOSCALZO J. - EDRF modulates the atherothrombogenic effects of homocysteine. J. Cardiovascular. Pharmacol., 1992, 20 : S202-204.
42. STAMPFER M.-J., MALINOW M.-R., WILLETT W.-C., NEWCOMER L.-M., UPSON B., ULLMANN D., TISHLER P.V., HENNEKENS C.-H. - A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA, 1992, 268 : 877-881.
43. STARKEBAUM G., HARLAN J.-M. - Endothelial cell injury due to copper-catalysed hydrogen peroxyde generation from homocysteine. J. Clin. Invest., 1986, 77: 1370-1376.
44. UBBINK J.-B., VAN DER MERWE A., VERMAAK W.-J.-H , DELPORT R. - Hyperhomocysteinemia and the response to vitamin supplementation. Clin. Invest., 1993, 71 : 993-998.
45. UBBINK J.-B., VERMAAK W.-J.-H., VAN DER MERWE A., BECKER P.-J., DELPORT R., POTGIETER H.-C. - Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutr., 1994, 124 : 1927-1933.
46. UELAND M., REFSUM H. - Plasma homocysteine, a risk factor for vascular disease : plasma levels in health, disease, and drug therapy. J. Clin. Lab. Med. 114 : 473-501.
47. VAN DER BERG M. - Combined vitamin B6 plus folic acid therapy in young patients with atheriosclerosis and hyperhomocysteinemia. J. Vasc. Surg., 1994, 20 : 933-940.
48. WALL R.-T., HARLAN J.-M., HARKER L.-A., STRIKER G.-E. - Homocysteine induced endothelial cell injury in vitro : a model for the study of vascular injury. Thromb. Res., 1980, 18: 113-121.
49. WILCKEN D.-E.-L., DUDMAN N.-P.-B. - Mechanisms of thrombogenesis and accelereted atherogenesis in homocysteinemia. Haemostatis, 1989, 19 (suppl. 1) : 14-23.
50. WILCKEN D.-E.-L., WILCKEN B., DUDMAN K-P., TYRRELL P-A. - Homocystinuria. The effects of betaine in the treatment of patients not responsive to pyridoxine. N. Engl. J. Med., 1983, 309 : 448-453.
51. WILCKEN D.-E.-L., REDDY G.-S.-R., GRYTA V.-J. - Homocysteinemia, ischémic heart disease, and the carrier state for homoeystinuria. Metabolism, 1983, 32 : 363-370.
52. WILKEN D.-E.-L., WILKEN B. - The pathogenesis of coronary artery disease : a possible role for methionine metabolism. J. Clin. Invest., 1976, 57 : 1079-1082.